当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析

派林生物

(000403)

  

流通市值:205.41亿  总市值:218.87亿
流通股本:6.88亿   总股本:7.33亿

派林生物(000403)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.22亿元,每股收益0.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益754455.01万元,未分配利润195756.10万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产871780.70万元,负债117325.68万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入435,640,719.292,328,723,280.441,374,813,312.16709,071,800.34
营业总成本297,485,500.881,639,495,501.11,033,269,820.34572,349,333.11
营业利润149,114,003.51695,187,632.41372,635,563.9161,363,516.76
利润总额140,949,650.07688,108,822.6370,068,990.92159,329,317.41
净利润121,869,775.56611,472,470.99325,813,319.79143,000,998.94
其他综合收益1,014.211,039.3820,987.3525,570.44
综合收益总额121,870,789.76611,483,510.37325,834,307.14143,026,569.38
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,441,910,520.513,426,074,653.63,072,354,748.783,034,930,803.35
非流动资产合计5,275,896,432.445,204,399,430.935,172,254,458.45,052,359,803.19
资产总计8,717,806,952.958,630,474,084.538,244,609,207.188,087,290,606.54
流动负债合计859,095,386.9922,194,565.38844,740,272.45910,522,704.23
非流动负债合计314,161,424.24286,415,637.35270,609,346.77244,065,037.82
负债合计1,173,256,811.141,208,610,202.731,115,349,619.221,154,587,742.05
归属于母公司股东权益合计7,551,538,502.257,428,649,258.067,135,337,662.826,938,535,011.9
股东权益合计7,544,550,141.817,421,863,881.87,129,259,587.966,932,702,864.49
负债和股东权益合计8,717,806,952.958,630,474,084.538,244,609,207.188,087,290,606.54
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计564,474,916.42,587,523,845.941,652,733,408.581,031,931,079.86
经营活动现金流出小计616,337,267.81,908,517,515.341,427,000,210.4875,546,656.74
经营活动产生的现金流量净额-51,862,351.4679,006,330.6225,733,198.18156,384,423.12
投资活动现金流入小计181,896,596.18836,502,637.27529,327,122.16320,219,113.11
投资活动现金流出小计622,268,521.761,125,713,935.011,002,038,970.4657,525,425.33
投资活动产生的现金流量净额-440,371,925.58-289,211,297.74-472,711,848.24-337,306,312.22
筹资活动现金流入小计117,675,001.94446,621,746.99386,892,834.67279,833,022.62
筹资活动现金流出小计66,075,930.58408,384,849.88358,440,681209,986,924.05
筹资活动产生的现金流量净额51,599,071.3638,236,897.1128,452,153.6769,846,098.57
汇率变动对现金及现金等价物的影响3,817.82-23,42964,616.4778,428.73
现金及现金等价物净增加额-440,631,387.8428,008,500.97-218,461,879.92-110,997,361.8
期末现金及现金等价物余额987,647,622.31,428,279,010.1782,073,629.21889,273,147.33
最新报告期:2024-04-14
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
东吴证券朱国广1.091.44--2024-04-14
TOP↑